Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 5.1.1.1 extracted from

  • Nakatani, Y.; Opel-Reading, H.K.; Merker, M.; Machado, D.; Andres, S.; Kumar, S.S.; Moradigaravand, D.; Coll, F.; Perdigao, J.; Portugal, I.; Schoen, T.; Nair, D.; Devi, K.R.U.; Kohl, T.A.; Beckert, P.; Clark, T.G.; Maphalala, G.; Khumalo, D.; Diel, R.; Klaos, K.; Aung, H.L.; Cook, G.M.; Parkhill, J.; Peaco, S.J.; Swaminathan, S.; Viveiros, M.; Niemann,S.; Krause, K.L.; K๖ser, C.U.
    Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance (2017), Antimicrob. Agents Chemother., 61, e01575-17 .
    View publication on PubMedView publication on EuropePMC

Protein Variants

Protein Variants Comment Organism
M319T the M319T mutation is positioned close enough to allow interaction with the D-cycloserine moiety, which, given the large change of the character of the side chain, can strongly affect D-cycloserine reactivity. M319 is located near Y364 and, as a result, it is possible that the M319T mutation alters the interaction with Y364, thereby affecting D-cycloserine inhibition. The M319T mutant enzyme shows minimal inhibition by D-cycloserine, even at 1 mM, the IC50 of this mutant cannot be determined Mycobacterium tuberculosis
R373L the mutation is not directly located within the active site but near the dimer interface and close to residues M319 and D320, which play an important role in the makeup of the active site. The replacement of arginine with the short and hydrophobic side chain of leucine might disrupt molecular interactions at the dimer interface as well as destabilize the DCS binding site. The R373L mutation is not located directly within the active site, but also showa a significant increase in resistance to D-cycloserine, with an 27fold increased IC50 compared to the wild-type enzyme Mycobacterium tuberculosis
Y364D the mutation to aspartic acid introduces a shorter and negatively charged side chain, which potentially affects pyridoxal 5'-phosphate orientation in the active site. The IC50 of the Y364D mutant for D-cycloserine shows a 50fold increase compared to the wild-type Mycobacterium tuberculosis

Inhibitors

Inhibitors Comment Organism Structure
D-cycloserine DCS, inhibits enzyme Alr irreversibly by covalently bonding to pyridoxal 5'-phosphate, molecular modeling Mycobacterium tuberculosis

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
L-alanine Mycobacterium tuberculosis
-
D-alanine
-
r

Organism

Organism UniProt Comment Textmining
Mycobacterium tuberculosis
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
L-alanine
-
Mycobacterium tuberculosis D-alanine
-
r

Subunits

Subunits Comment Organism
homodimer
-
Mycobacterium tuberculosis

Synonyms

Synonyms Comment Organism
AlrMtb
-
Mycobacterium tuberculosis

Cofactor

Cofactor Comment Organism Structure
pyridoxal 5'-phosphate
-
Mycobacterium tuberculosis

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.0264
-
wild-type enzyme, pH and temperature not specified in the publication Mycobacterium tuberculosis D-cycloserine
0.712
-
enzyme mutant R373L, pH and temperature not specified in the publication Mycobacterium tuberculosis D-cycloserine
1.328
-
enzyme mutant Y364D, pH and temperature not specified in the publication Mycobacterium tuberculosis D-cycloserine

General Information

General Information Comment Organism
malfunction role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance, overview Mycobacterium tuberculosis
additional information amino acid residues 319 and 364 are located directly in the active site. Y364 is involved in the positioning of the phosphate moiety of PLP and thus represents a prominent active site residue in the conserved inner layer of the substrate entrance corridor of Alr Mycobacterium tuberculosis